Drugs Made In America Acquisition II Corp. Ordinary Shares
DMIINASDAQ · Financial Services · Financial - ConglomeratesDrugs Made In America Acquisition II Corp. does not have significant operations.
$10.23+0.20%
报价 2026-11-09
市值
$651.7M
EV
$4.6M
PE (TTM)
–
预期 PE
–
52 周区间距高点 0.0%
$9.87$10.23
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-09数据不足：no_fresh_estimates
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Financial - Conglomerates| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | $651.7M | +0.2% | – | 0% | – | – | – | |
| TREELendingTree, Inc. | $512.3M | -1.4% | +20.4% | 96% | 5.0x | 5.6x | 6.4x | Cheap GARP |
| BCSSTavia Acquisition Corp. | $479.8M | -0.0% | – | 0% | – | – | – | |
| CXIIChurchill Capital Corp. Xii | $432.9M | +0.2% | – | – | – | – | – | |
| XIIIChurchill Capital Corp. Xiii | $425.4M | +0.6% | – | – | – | – | – | |
| AACAres Acquisition Corp. III Class A | $399M | +1.8% | – | – | – | – | – | |
| BRTMB&R Technology Merger Corp. | $359.3M | +0.2% | – | – | – | – | – | |
| KBONKarbon Capital Partners Corp. | $358.4M | +0.2% | – | – | – | – | – | |
| ARCIArchimedes Tech SPAC Partners III Co. | $355.8M | +0.1% | – | – | – | – | – | |
| 同行中位数 | – | – | +20.4% | 48% | 5.0x | 5.6x | 6.4x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。